Minimum Effective Volume of Lidocaine-Bupivacaine for Subgluteal Block
NCT ID: NCT02571699
Last Updated: 2016-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2016-03-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Minimum Effective Volume of Lidocaine Costoclavicular Brachial Plexus Block
NCT02932670
Sciatic Nerve Block Using the Subgluteal Space Approach: A Comparison With the Infragluteal Approach
NCT01814605
Comparison of the Sensitive Cutaneous Block Distribution Following Femoral Nerve Block Using Two Femoral Block Techniques
NCT02721290
Popliteal Sciatic Nerve Block Catheter Placement for Foot Surgery
NCT01049906
Sciatic Nerve Blockade by Subgluteal Access 12.5 ml of 1% Lidocaine: US Guidance Versus US Guidance With Electrical Stimulation of Peripheral Nerves (Influence of the Sciatic Nerve Blockade on the Effectiveness of Small Doses of Local Anesthetic.).
NCT05205473
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Success rate is defined as a minimal composite score of 6 points (out of 8 points) at 30 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subgluteal sciatic block
Subgluteal block with similar volume
Subgluteal Nerve Block
ultrasound-guided subgluteal sciatic nerve block.
Subgluteal block
Subgluteal block with decreasing volume
Subgluteal Nerve Block
ultrasound-guided subgluteal sciatic nerve block.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Subgluteal Nerve Block
ultrasound-guided subgluteal sciatic nerve block.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists classification 1-3
* body mass index between 20 and 35
Exclusion Criteria
* pre-existing neuropathy (assessed by history and physical examination)
* coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets≤ 100, International Normalized Ratio≥ 1.4 or partial prothrombin time ≥ 50)
* renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)
* hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)
* allergy to LA
* pregnancy
* prior surgery in the subgluteal region
* chronic pain syndromes requiring opioid intake at home
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
De Tran
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
De Tran, MD, FRCPC
Role: PRINCIPAL_INVESTIGATOR
McGill University Health Centre/Research Institute of the McGill University Health Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montreal General Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
MontrealGH
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Roderick J Finlayson, MD, FRCPC
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MGH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.